Pictet Asset Management (UK)’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-824,059
Closed -$10.2M 1754
2020
Q3
$10.2M Sell
824,059
-228,277
-22% -$2.68M 0.02% 552
2020
Q2
$7.49M Buy
1,052,336
+109,635
+12% +$734K 0.01% 587
2020
Q1
$5.12M Sell
942,701
-65,540
-7% -$585K 0.01% 633
2019
Q4
$9.13M Sell
1,008,241
-9,430
-0.9% -$76.6K 0.02% 615
2019
Q3
$7.32M Sell
1,017,671
-22,969
-2% -$165K 0.02% 608
2019
Q2
$8.27M Buy
1,040,640
+61,583
+6% +$729K 0.02% 561
2019
Q1
$12.3M Buy
979,057
+302,680
+45% +$4.79M 0.03% 493
2018
Q4
$13.5K Sell
676,377
-337,654
-33% -$7.81M 0.03% 444
2018
Q3
$28.8M Sell
1,014,031
-101,699
-9% -$2.43M 0.06% 335
2018
Q2
$23.5M Sell
1,115,730
-224,195
-17% -$4.24M 0.06% 367
2018
Q1
$19.1M Buy
1,339,925
+263,548
+24% +$3.77M 0.05% 388
2017
Q4
$13.2M Buy
+1,076,377
New +$15.2M 0.03% 453

Other funds holding EVH

Pictet Asset Management (UK)'s EVH Position: Q4 2020 in Review

Pictet Asset Management (UK) sold out of Evolent Health (EVH) in Q4 2020, closing a stake of 824,059 shares — an estimated $10.2M sold.

Pictet Asset Management (UK) first reported a position in EVH in Q4 2017 and held it in 12 quarters. The position peaked at $28.8M in Q3 2018. 161 funds tracked by Wall St. Rank hold EVH as of Q4 2020.

  • Pictet Asset Management (UK) reported no remaining Evolent Health position as of Q4 2020 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 824,059 Evolent Health shares in Q4 2020, an estimated $10.2M.
  • Pictet Asset Management (UK) first reported a position in Evolent Health in Q4 2017 and held it in 12 quarters.
  • Pictet Asset Management (UK)'s Evolent Health position peaked at $28.8M in Q3 2018.
  • 161 funds tracked by Wall St. Rank held Evolent Health as of Q4 2020.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2020, filed 16 Feb 2021.